RECOVERY FROM CYTOMEGALOVIRUS-INFECTION IS ASSOCIATED WITH ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES

被引:43
作者
VANDENBERG, AP [1 ]
VANSON, WJ [1 ]
JANSSEN, RAJ [1 ]
BRONS, NHC [1 ]
HEYN, AA [1 ]
SCHOLTENSAMPSON, A [1 ]
POSTMA, S [1 ]
VANDERGIESSEN, M [1 ]
TEGZESS, AM [1 ]
DELEIJ, LHFM [1 ]
THE, TH [1 ]
机构
[1] UNIV GRONINGEN HOSP, RENAL TRANSPLANT UNIT, 9713 EZ GRONINGEN, NETHERLANDS
来源
JOURNAL OF INFECTIOUS DISEASES | 1992年 / 166卷 / 06期
关键词
D O I
10.1093/infdis/166.6.1228
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The number of CD8bright and CD56+ lymphocytes in the peripheral blood and their activation status were monitored by flow cytometry in 23 renal transplant recipients with cytomegalovirus (CMV) infection and were correlated with the virus load (as determined by CMV antigenemia) and clinical symptoms. Recovery from CMV infection coincided with expansion of the CD8bright and CD56+ subsets and with increased expression of the activation marker HLA-DR. Primary infection was associated with activation of both subsets, whereas during secondary infection, mainly CD8bright cells responded. Progressive CMV disease (requiring antiviral treatment) and relapse occurred in association with low numbers of activated CD8bright and CD56+ cells. Lymphocyte activation and antibody responses against CMV often occurred simultaneously, but different kinetics of these responses in some patients indicated that cellular responses are necessary to control viral replication, whereas humoral responses alone may be insufficient. Monitoring of lymphocyte activation may provide clinically useful information during CMV infection.
引用
收藏
页码:1228 / 1235
页数:8
相关论文
共 33 条
  • [1] SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS
    BIRON, CA
    BYRON, KS
    SULLIVAN, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) : 1731 - 1735
  • [2] IMMUNOSUPPRESSIVE EFFECTS OF GANCICLOVIR ON INVITRO LYMPHOCYTE-RESPONSES
    BOWDEN, RA
    DIGEL, J
    REED, EC
    MEYERS, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (06) : 899 - 903
  • [3] ADOPTIVE TRANSFER STUDIES DEMONSTRATING THE ANTIVIRAL EFFECT OF NATURAL-KILLER CELLS INVIVO
    BUKOWSKI, JF
    WARNER, JF
    DENNERT, G
    WELSH, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (01) : 40 - 52
  • [4] CARNEY WP, 1981, J IMMUNOL, V126, P2114
  • [5] TREATMENT OF INVASIVE CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT PATIENTS WITH GANCICLOVIR
    DUNN, DL
    MAYORAL, JL
    GILLINGHAM, KJ
    LOEFFLER, CM
    BRAYMAN, KL
    KRAMER, MA
    ERICE, A
    BALFOUR, HH
    FLETCHER, CV
    BOLMAN, RM
    MATAS, AJ
    PAYNE, WD
    SUTHERLAND, DER
    NAJARIAN, JS
    [J]. TRANSPLANTATION, 1991, 51 (01) : 98 - 106
  • [6] ENRICE A, 1987, JAMA-J AM MED ASSOC, V257, P3082
  • [7] QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS VIREMIA BY USING MONOCLONAL-ANTIBODIES TO DIFFERENT VIRAL-PROTEINS
    GERNA, G
    REVELLO, MG
    PERCIVALLE, E
    ZAVATTONI, M
    PAREA, M
    BATTAGLIA, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) : 2681 - 2688
  • [8] GREFTE JMM, 1991, INT CONGR SER, V978, P233
  • [9] GANCICLOVIR THERAPY OF SEVERE CYTOMEGALO-VIRUS INFECTIONS IN SOLID-ORGAN TRANSPLANT RECIPIENTS
    HARBISON, MA
    DEGIROLAMI, PC
    JENKINS, RL
    HAMMER, SM
    [J]. TRANSPLANTATION, 1988, 46 (01) : 82 - 88
  • [10] HO M, 1990, REV INFECT DIS, V12, pS701